Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Mouse, Rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Peptide sequence around phosphorylation site of tyrosine 410(G-V-Y(p)-A-V) derived from Human p130 Cas .|
|Storage buffer||PBS, pH 7.4, with 50% glycerol|
|Contains||0.02% sodium azide|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:50-1:100|
|Western Blot (WB)||1:500-1:1000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
A suggested positive control for Western blot is K562 or NIH-3T3 cells; suggested positive control for IHC is human breast carcinoma.
Docking protein which plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion. Implicated in induction of cell migration. Overexpression confers anti-estrogen resistance on breast cancer cells.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
BCA1; BCAR1; breast cancer anti-estrogen resistance 1; Breast cancer anti-estrogen resistance 1 protein; breast cancer anti-estrogen resistance protein 1; Cas scaffolding protein family member 1; CRK-associated substrate; Crk-associated substrate p130Cas; CRKAS; p130 Cas; p130cas; v-crk-associated tyrosine kinase substrate
AI385681; BCAR1; CAS; CAS1; CASS1; CRKAS; P130CAS